Follow the 동국제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 동국제약 has recorded 21 reports. The latest transaction was reported on 26 May 2026 (Sale). Among the most active insiders: 브이아이피자산운용. All data is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
14 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.